Revenue and profits are climbing at Dr. Martens, the iconic British brand, according to first half results for the period ended 30 September 2021.
Revenue grew 16% to £369.9m at the Northamptonshire-headquartered company, in comparison to £318.2m in the same period last year.
Profit before tax meanwhile was up 46% at £61.3m, in comparison to £41.9m last year.
Kenny Wilson, Chief Executive Officer, said: “Our strong performance in the first half is testament to the strength of our business model, the under penetration of our brand globally, our agility in adapting to changing conditions and the passion and dedication of our people.
“We continue to take a long-term custodian approach to growing the brand, prioritising DTC channels and our seven priority markets. At the start of the period we took Italy and Iberia back under direct control and we are very pleased with their performance to date.
“We took the decision to enter the year with higher inventory levels, made possible by the continuity and carryover nature of our product and our partnership approach to supplier relationships.
“This meant that DTC availability levels remained relatively high and gross margin was not impacted, despite the supply chain disruption and global shipping delays experienced across the industry. Our Americas performance was again particularly strong, notwithstanding our wholesale business here being most impacted by these delays.
“Our strong first half performance combined with the continued momentum in DTC trading into the second half gives us confidence in achieving market expectations for the full year. I remain hugely excited about the growth potential of the Dr. Martens brand.”
